/

Empresas

Av

No verificado

Avenacy

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaSaludSanidad

28 Comunicados de prensa

Ver todos los comunicados de prensa

08/09/2026

Multimedia

Industria

Biotecnología

Farmacéutica

Oncología

Salud

Higiene alimentaria

Material médico sanitario

Medicina - Varios

Avenacy Announces Launch of Cyclophosphamide for Injection, USP in the U.S. Market

Fuente

Editor

1.00

0

29/06/2026

Avenacy Announces Launch of Norepinephrine Bitartrate Injection, USP in the U.S. Market

Fuente

Editor

1.00

0

17/06/2026

Avenacy Announces Launch of Bortezomib for Injection in the U.S. Market

Fuente

Editor

1.00

0

11/05/2026

Avenacy Announces Launch of Ready-to-Use Tranexamic Acid in 0.7% Sodium Chloride Injection in the U.S. Market

Fuente

Editor

1.00

0

16/03/2026

Eventos

Biotecnología

Farmacéutica

Salud

Avenacy to Attend 2026 DCAT Week

Fuente

Editor

1.00

0

02/03/2026

Avenacy Announces Launch of Diphenhydramine Hydrochloride Injection, USP in the U.S. Market

Fuente

Editor

1.00

0

08/01/2026

Eventos

Biotecnología

Sanidad

Farmacéutica

Salud

Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference

Fuente

Editor

1.00

0

17/12/2025

Eventos

Biotecnología

Farmacéutica

Salud

Avenacy to Attend J.P. Morgan 44th Annual Healthcare Conference

Fuente

Editor

1.00

0

03/12/2025

Farmacéutica

Salud

Sanidad

Material médico sanitario

Eventos

Industria

Avenacy to Attend 2025 ASHP Midyear Clinical Meeting and Exhibition

Fuente

Editor

1.00

0

22/10/2025

Eventos

Ferias y Congresos

Salud

Farmacéutica

Avenacy to Highlight 2025 Achievements and Partnership Opportunities at CPHI Frankfurt

Fuente

Editor

1.00

0

Seguidores

0

Compatibilidad

0